Business Context and Reporting Period
This Form 8-K was filed by The Chemours Company on June 10, 2019. The report discloses an "Other Event" (Item 8.01) regarding an amendment to the 10b5-1 trading plan of Mark P. Vergnano, President and Chief Executive Officer.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to a specific executive stock transaction:
- Shares Purchased: 44,000 shares of Chemours common stock.
- Aggregate Cost: Approximately $1,019,000.
- Post-Transaction Ownership: Mr. Vergnano owns a total of 690,254 shares.
Material Changes
The material change reported is the amendment of Mr. Vergnano's 10b5-1 trading plan, originally filed on March 15, 2018. The amendment was made to allow the CEO to purchase shares of the company. No material changes to the company's financial condition or operations are reported in this document.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future business performance. It includes a standard disclaimer stating that Chemours undertakes no obligation to report future modifications or terminations of the trading plan or other trading plans by officers or directors, except as required by law.
Key Facts for Investor Verification
- Verify the total share ownership of CEO Mark P. Vergnano (690,254 shares) following the June 10, 2019 purchase.
- Confirm the aggregate cost of the open market purchase was approximately $1,019,000.
- Note that this filing is strictly an executive compensation/trading disclosure and does not contain quarterly or annual financial results.